Cidofovir in the treatment of cytomegalovirus (CMV) retinitis

By Garcia Claudio R.   Torriani Francesca J.   Freeman William R.  

Ocular Immunology and Inflammation, Vol. 6, Iss. 3, 1998-09 ,pp. : 195-203

Informa Healthcare

Access to resources Recommend Favorite

Human herpesvirus-6 in renal transplant recipients: potential risk factors for the development of human herpesvirus-6 seroconversion

By Deborska D.   Durlik M.   Sadowska A.   Nowacka-Cieciura E.   Pazik J.   Lewandowski Z.   Chmura A.   Galazka Z.   Paczek L.   Lao M.  

Transplantation Proceedings, Vol. 35, Iss. 6, 2003-09 ,pp. : 2199-2201

Elsevier

Access to resources Recommend Favorite

Clinical pattern, risk factors, and outcome of CMV infection in renal transplant recipients: local experience

By Yeung J.S.   Tong K.L.   Chan H.W.H.  

Transplantation Proceedings, Vol. 30, Iss. 7, 1998-11 ,pp. : 3144-3145

Elsevier

Access to resources Recommend Favorite

Oral Ganciclovir in the Prevention of Cytomegalovirus Infection in Postkidney Transplant ''CMV at Risk'' Recipients: A Controlled, Comparative Study of Two Regimens (750 mg Bid and 500 mg Bid)

By Ahsan N.   Holman M.J.   Sonderbye L.   Langhoff E.   Yang H.C.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1383-1385

Elsevier

Access to resources Recommend Favorite

Renal allograft outcome from cytomegalovirus seronegative donor into cytomegalovirus seronegative recipient: poor prognosis after seroconversion

By Besse T.   Malaise J.   De Meyer M.   Mourad M.   Squifflet J.P.  

Transplantation Proceedings, Vol. 32, Iss. 2, 2000-03 ,pp. : 408-410

Elsevier

Access to resources Recommend Favorite